17 May 2023
Steve Rees, VP of screening sciences and sample management at AstraZeneca, discusses how combing acoustic liquid handling and mass spectrometry can increase throughput of samples and decrease assay development costs by up to 1000-fold. Find out how AstraZeneca’s partnership with Labcyte will impact metabolomics and drug discovery screening.
AstraZeneca
Dr. Jonathan Wingfield is a Principal Scientist within the Screening Sciences and Sample Management function Discovery Sciences at AstraZeneca. He provides scientific leadership to his team, focusing on addressing the key questions facing early drug discovery through high quality science and innovative application of technology. His team work on projects on high-throughput mass spectrometry and intracellular surface-enhanced Raman spectroscopy in the investigation of nanomaterial interactions and the understanding of biochemical pathways and pharmacodynamics.